Please try another search
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals. It operates through Generic Pharmaceuticals and OTC Products segments. The company is developing Adva-27a, a Topoisomerase II inhibitor to treat aggressive forms of cancer, as well as multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; SBFM-PL4, a protease inhibitor for the treatment of SARS Coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; L-Citrulline; Taurine. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant use. Sunshine Biopharma, Inc. is headquartered in New York, New York.
Name | Age | Since | Title |
---|---|---|---|
Rabi Kiderchah | 51 | 2021 | Independent Director |
Andrew Mark Keller | 70 | 2022 | Independent Director |
David Natan | 71 | 2022 | Independent Director |
Abderrazzak Merzouki | 60 | 2016 | Chief Science Officer & Director |
Steve N. Slilaty | 72 | 2009 | CEO, President & Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review